Analysis of cellular molecules associated with keratinocyte differentiation

与角质形成细胞分化相关的细胞分子分析

基本信息

  • 批准号:
    14570794
  • 负责人:
  • 金额:
    $ 2.24万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    2002
  • 资助国家:
    日本
  • 起止时间:
    2002 至 2005
  • 项目状态:
    已结题

项目摘要

We studied peptidylarginine deiminases (PADs) expression in human epidermis (Cell Mol Life Sci 2005). We found that PAD1,2 and 3 are expressed. PAD1 and PAD3 are co-localized with filaggrin. PAD was present up to the supper corneocytes where it deiminates keratin K1.We have shown that LEKI is localized in lamellar granules, separated from KLK5 and KLK7, and is secreted in the extracellular spaces of the superficial stratum granulosum in the epidermis (J Invest Dermatol 2005).We also disclosed that in Netherton syndrome where LEKTI is absent, an abnormal split was seen in the superficial stratum granulosum, suggesting that LEKTI is preventing premature loss of stratum corneum cohesion.We generated SPINK5-deficient mice as a model for Netherton syndrome. Using this model, we showed that desmosome cleavage due to desmoglein 1 degradation is the primary pathogenic event in this disease. (Nature Genetics 2005).We describe a novel neurocutaneous syndrome characterized by cerebral dysgenesis, neuropathy, ichthyosis, and keratoderma (CEDNIK syndrome) caused by a mutation in SNAP29, coding for a SNARE protein involved in intracellular trafficking (Am J Hum Genet 2005). In the ichthyotic patient skin, secretion of lamellar granule proteins was inhibited.We have identified novel members of lamellar granule proteins, namely A2ML (alpha-2 macroglobulin-like) and Dermokin (J Biol Chem, 2006,J Invest Dermatol 2006).
我们研究了人表皮中肽基精氨酸脱亚胺酶(PAD)的表达(Cell Mol Life Sci 2005)。我们发现PAD 1、2和3表达。PAD 1和PAD 3与聚丝蛋白共定位。PAD存在于角质形成细胞的上层,在那里它将角蛋白K1脱亚氨基化。我们已经证明LEKI定位于与KLK 5和KLK 7分离的板层颗粒中,并分泌于表皮浅层颗粒层的细胞外间隙中(J Invest Dermatol 2005)。我们还披露,在LEKTI缺失的内瑟顿综合征中,在浅表颗粒层中观察到异常分裂,提示LEKTI可以预防角质层凝聚力的过早丧失。我们建立了SPINK 5缺陷小鼠作为内瑟顿综合征的模型。使用这个模型,我们表明,桥粒分裂由于桥粒芯蛋白1降解是在这种疾病的主要致病事件。我们描述了一种新的神经皮肤综合征,其特征在于由编码参与细胞内运输的SNARE蛋白的SNAP 29中的突变引起的脑发育不全、神经病、鱼鳞病和角化病(CEDNIK综合征)(Am J Genet 2005)。我们已经鉴定了板层颗粒蛋白的新成员,即A2 ML(α-2巨球蛋白样)和Dermokin(J Biol Chem,2006,J Invest Dermatol 2006)。

项目成果

期刊论文数量(77)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Periplakin gene targeting reveals a constituent of the cornified cell envelope dispensable for normal mouse development
  • DOI:
    10.1128/mcb.24.14.6410-6418.2004
  • 发表时间:
    2004-07-01
  • 期刊:
  • 影响因子:
    5.3
  • 作者:
    Aho, S;Li, KH;Klement, JF
  • 通讯作者:
    Klement, JF
Akemi Ishida-Yamamoto, et al.: "Lessons from disorders of epidermal differentiatin-associated keratins"Histology and Histopathology. 17. 331-338 (2002)
Akemi Ishida-Yamamoto 等人:“表皮分化相关角蛋白疾病的教训”组织学和组织病理学。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Immunolocalization of target autoantigens in IgA pemphigus
  • DOI:
    10.1111/j.1365-2230.2004.01436.x
  • 发表时间:
    2004-01-01
  • 期刊:
  • 影响因子:
    4.1
  • 作者:
    Ishii, N;Ishida-Yamamoto, A;Hashimoto, T
  • 通讯作者:
    Hashimoto, T
Akemi Ishida-Yamamoto: "Loricrin keratoderma. A novel disease entity characterized by nuclear accumulation of mutant loricrin"Journal of Dermatological Science. 31. 3-8 (2003)
Akemi Ishida-Yamamoto:“Loricrin keratoderma。一种以突变型 Loricrin 核积累为特征的新型疾病实体”皮肤病学杂志。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Prediction of a coding sequence for a novel type II keratin from N-terminal sequences of mouse epidermal proteins site-specifically deiminated in embryonic development.
从胚胎发育过程中位点特异性脱亚胺化的小鼠表皮蛋白的 N 端序列预测新型 II 型角蛋白的编码序列。
  • DOI:
  • 发表时间:
    2005
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Senshu T;Ishida-Yamamoto A;Takahashi H;Iizuka H.
  • 通讯作者:
    Iizuka H.
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

YAMAMOTO Akemi其他文献

YAMAMOTO Akemi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('YAMAMOTO Akemi', 18)}}的其他基金

Pathological mechanisms of keratinization abnormalities
角化异常的病理机制
  • 批准号:
    19591294
  • 财政年份:
    2007
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Cell biological analyses of cornified cell envelope formation
角质化细胞包膜形成的细胞生物学分析
  • 批准号:
    10470184
  • 财政年份:
    1998
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B).
Expression and Abnormalities of Keratinocyte Terminal Differentiation-Associated Proteins
角质形成细胞终末分化相关蛋白的表达及异常
  • 批准号:
    08670940
  • 财政年份:
    1996
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似国自然基金

三角帆蚌丝氨酸蛋白酶(serine protease)基因的克隆、表达调控与功能研究
  • 批准号:
    31040083
  • 批准年份:
    2010
  • 资助金额:
    10.0 万元
  • 项目类别:
    专项基金项目

相似海外基金

The underlying dynamic exchange that dictates serine protease function
决定丝氨酸蛋白酶功能的潜在动态交换
  • 批准号:
    2332239
  • 财政年份:
    2024
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Standard Grant
The Serine Protease HTRA1 Antigen: A Gateway to Elucidating Membranous Nephropathy Pathogenesis and the Targeting of Antigen Epitopes
丝氨酸蛋白酶 HTRA1 抗原:阐明膜性肾病发病机制和抗原表位靶向的途径
  • 批准号:
    10740614
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
COVID-19 Variant Supplement - Preventing SARS-CoV-2 infection by targeting human type II transmembrane serine protease activity
COVID-19 变异补充剂 - 通过靶向人类 II 型跨膜丝氨酸蛋白酶活性来预防 SARS-CoV-2 感染
  • 批准号:
    443033
  • 财政年份:
    2021
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Operating Grants
Sex as a Biological Variable Supplement - Preventing SARS-CoV-2 infection by targeting human type II transmembrane serine protease activity
性别作为生物变量补充剂 - 通过靶向人类 II 型跨膜丝氨酸蛋白酶活性预防 SARS-CoV-2 感染
  • 批准号:
    424692
  • 财政年份:
    2020
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Operating Grants
Preventing SARS-CoV-2 infection by targeting human type II transmembrane serine protease activity
通过靶向人 II 型跨膜丝氨酸蛋白酶活性预防 SARS-CoV-2 感染
  • 批准号:
    422696
  • 财政年份:
    2020
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Operating Grants
The effects of serine protease inhibition on the polycystic kidney disease
丝氨酸蛋白酶抑制对多囊肾病的影响
  • 批准号:
    20K08638
  • 财政年份:
    2020
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Pathophysiology and Treatment of Eosinophilic Inflammation Targeting Serine Protease Inhibitors
丝氨酸蛋白酶抑制剂靶向嗜酸性粒细胞炎症的病理生理学和治疗
  • 批准号:
    20K09719
  • 财政年份:
    2020
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Study on regulation of serine protease activity in carcinogenesis of oral squamous cell carcinoma
丝氨酸蛋白酶活性在口腔鳞癌癌变过程中的调控研究
  • 批准号:
    20K18483
  • 财政年份:
    2020
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Serine protease expression and its biological significance in AML
丝氨酸蛋白酶在AML中的表达及其生物学意义
  • 批准号:
    19K08810
  • 财政年份:
    2019
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development of new serine protease inhibitors by optimisation of rationally designed covalent S1 fragments
通过优化合理设计的共价S1片段开发新型丝氨酸蛋白酶抑制剂
  • 批准号:
    2301483
  • 财政年份:
    2019
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Studentship
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了